| Literature DB >> 26415513 |
Lorena Romero-Jiménez1, David Rodríguez-Carbonell2, María Trinidad Gallegos3, Juan Sanjuán4, Daniel Pérez-Mendoza5.
Abstract
BACKGROUND: The cyclic diguanylate (c-di-GMP) is currently considered an ubiquitous second messenger in bacteria that influences a wide range of cellular processes. One of the methodological approaches to unravel c-di-GMP regulatory networks involves raising the c-di-GMP intracellular levels, e.g. by expressing a diguanylate cyclase (DGC), to provoke phenotypic changes.Entities:
Mesh:
Substances:
Year: 2015 PMID: 26415513 PMCID: PMC4587759 DOI: 10.1186/s12866-015-0521-6
Source DB: PubMed Journal: BMC Microbiol ISSN: 1471-2180 Impact factor: 3.605
Fig. 1Mini-Tn7 delivery constructions originated from pUC18T-mini-Tn7T suicide plasmid. The pleD* gene, under the lac promoter, was cloned between the Tn7 Left and Right ends. Downstream pleD* Tetracycline and Kanamycin resistance genes were cloned to facilitate selection. Vectors with resistance genes but without pleD*, were obtained after removing a NcoI internal fragment to pleD*. ApR, KmR, TcR stand for resistance to Ampicillin, Kanamycin and Tetracycline, respectively; MCS, multi-cloning site; T0T1, transcriptional terminators from bacteriophage λ and E. coli rrnB operon, respectively; Tn7L and Tn7R, left and right ends of Tn7 transposon, respectively; P, lac promoter
Transposition efficiencies of mini-Tn7 constructs
| Recipient strain | Mini-Tn | Frequencya |
|---|---|---|
|
| Tn | 3,0 x 10−4 |
| Tn | 6,5 x 10−6 | |
| Tn | 5,2 x 10−6 | |
| Tn | 9,8 x 10−8 | |
| Tn | 5,1 x 10−6 | |
|
| Tn | 2,5 x 10−8 |
| Tn | 4,8 x 10−8 | |
| Tn | <10−9 | |
| Tn | 1,8 x 10−9 | |
|
| Tn | 4 x 10−8 |
| Tn | 8 x 10−8 | |
| Tn | 3,5 x 10−9 | |
| Tn | 2,3 x 10−8 | |
|
| Tn | 1,6 x 10−7 |
| Tn | 4,8 x 10−5 | |
| Tn | 7 x 10−8 | |
| Tn | 2 x 10−5 |
aMini-Tn7 frequency of transposition expressed as the number of transposants per input receptor cell
Fig. 2Quantification of intracellular c-di-GMP levels. c-di-GMP contents of Rhizobium etli CFN42 (Ret), Sinorhizobium meliloti 8530 (Sme), Rhizobium leguminosarum bv. viciae UPM791 (Rle) and Pseudomonas syringae pv. tomato DC3000 (Pto), with plasmid-encoded (pJBpleD*) or chromosomally integrated pleD* gene. Tc transposants in rhizobial strains displayed comparable phenotypes to Km and their c-di-GMP levels were not determined. Control strains without pleD* carried mini-Tn7Km or mini-Tn7Tc. Standard error of three biological replicates are shown
Fig. 3Quantification of calcofluor-derived fluorescence of R. etli CFN42 (Ret), R. leguminosarum bv. viciae UPM791 (Rle), S. meliloti 8530 (Sme), and P. syringae pv.tomato DC3000 (Pto) expressing plasmid-encoded (pJBpleD*) or chromosomally integrated pleD* gene, and their respective control strains. Mean values from three independent cultures ± standard deviation
Stability of plasmids and mini-Tn7 insertions in different strains
| Strain | Free-living stabilitya | Stability in symbiosisb |
|---|---|---|
| Ret pJB3Tc19 | 8,6 % | 98 % |
| Ret pJBpleD* | 0.6 % | 0 % |
| Ret Tn | 100 % | 100 % |
| Ret Tn | 100 % | 90 % |
| Ret Tn | 100 % | n.d. |
| Ret Tn | 100 % | n.d. |
| Rle pJB3Tc19 | 73,5 % | 86 % |
| Rle pJBpleD* | 67,1 % | 70 % |
| Rle Tn | 100 % | 100 % |
| RleTn | 100 % | 100 % |
| Rle Tn | 100 % | n.d. |
| Rle Tn | n.d | n.d. |
| Sme pJB3Tc19 | 2,8 % | 51 % |
| Sme pJBpleD* | 3,1 % | 22 % |
| Sme Tn | 100 % | 100 % |
| Sme Tn | 100 % | 91 % |
| Sme Tn | 100 % | n.d. |
| Sme Tn | 100 % | n.d. |
| Pto pJB3Tc19 | 100 % | n.d. |
| Pto pJBpleD* | 76,8 % | n.d. |
| Pto Tn | 100 % | n.d. |
| Pto Tn | 100 % | n.d. |
| Pto Tn | 100 % | n.d. |
| Pto Tn | 100 % | n.d. |
aBacteria were grown in rich medium without antibiotics for at least 100 generations; the stability was determined as the ratio of CFU recovered on selective medium out of the total CFU obtained in nonselective medium
bPercentage of nodules containing bacteria that kept antibiotic resistance (for more details see supporting information)
n.d., not determined
Efficacy of the lacI q-IPTG system to modulate pleD* expression
| Strain | Relative | Intracellular c-di-GMP 2 | EPS production3 | |||
|---|---|---|---|---|---|---|
| IPTG - | IPTG + | IPTG - | IPTG + | IPTG - | IPTG + | |
| Sme Tn | 15,11 ± 1,98 | n.d. | 317,16 ± 13,29 | n.d. | 2,66 × 106 ± 6,9 × 104 | 2,64 × 106 ± 7,34 × 104 |
| Sme Tn | 1,00 ± 0,26 | 6,08 ± 1,06 | 55,10 ± 16,27 | 152,05 ± 8,50 | 3,51 × 105 ± 1,19 × 104 | 2,23 × 106 ± 6,36 × 104 |
| Sme Tn | - | - | - | n.d. | 6,20 × 104 ± 5,54 × 103 | 7,39 × 104 ± 3,44 × 103 |
1Relative expression (fold change) to Sme Tn7pleD*Km pBBRlacIq strain without IPTG (repression state) by qRT-PCR. In all strains pleD* expression was normalized with to 16S rRNA levels
2pmol of c-di-GMP/mg of total protein. The c-di-GMP levels of Sme Tn7Km is under the technical limit of detection
3CF-derived Fluorescence (arbitrary units)
n.d., not determined